Optimizing retroviral gene expression for effective therapies

Human Gene Therapy

Volumn 24, Issue 4, 2013, Pages 363-374

  Antoniou, Michael N ^a   Skipper, Kristian Alsbjerg ^a,b   Anakok, Omer ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

CHROMATIN; DNA METHYLATION; EPIGENETIC REPRESSION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE INSERTION; GENE SILENCING; NONHUMAN; REVIEW; STEM CELL; TRANSGENE; VIRAL GENE THERAPY;

ANIMALS; CHROMATIN; DNA METHYLATION; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; LOCUS CONTROL REGION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RETROVIRIDAE; TRANSGENES;

EID: 84876575492     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.062     Document Type: Review

References (104)

1. Aiuti, A., Bacchetta, R., Seger, R., et al. (2012). Gene therapy for primary immunodeficiencies: part 2. Curr. Opin. Immunol. 24, 585-591.
2. Antoniou, M., Geraghty, F., Hurst, J., et al. (1998). Efficient 3¢-end formation of human b-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction. Nucleic Acids Res., 26, 721-729.
3. Antoniou, M., Harland, L., Mustoe, T., et al. (2003). Transgenes encompassing dual promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics 82, 269-279.
4. Arumugam, P., and Malik, P. (2010). Genetic therapy for b-thalassemia: from the bench to the bedside. Hematology Am. Soc. Hematol. Educ. Program 2010; 2010, 445-450.
5. Arumugam, P.I., Scholes, J., Perelman, N., et al. (2007). Improved human b-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol. Ther. 15, 1863-1871.
6. Arumugam, P.I., Higashimoto, T., Urbinati, F., et al. (2009a). Genotoxic potential of lineage-specific lentivirus vectors carrying the b-globin locus control region. Mol. Ther. 17, 1929-1937.
7. Arumugam, P.I., Urbinati, F., Velu, C.S., et al. (2009b). The 3¢ region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activity. PLoS One 4, e6995
8. Bandaranayake, A.D., Correnti, C., Ryu, B.Y., et al. (2011). Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res. 39, e143.
9. Barkess, G., and West, A.G. (2012). Chromatin insulator elements: establishing barriers to set heterochromatin boundaries. Epigenomics 4, 67-80.
10. Benton, T., Chen, T., McEntee, M., et al. (2002). The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology 38, 43-46.
11. Bestor, T.H. (2000). Gene silencing as a threat to the success of gene therapy. J. Clin. Invest. 105, 409-411.
12. Biffi, A., Aubourg, P., and Cartier, N. (2011). Gene therapy for leukodystrophies. Hum. Mol. Genet. 20, R42-53.
13. Blom van Assendelft, G., Hanscombe, O., Grosveld, F., et al. (1989). The b-globin dominant control region activates homologous and heterologous promoters in a tissue-specific manner. Cell 56, 969-977.
14. Bode, J., Goetze, S., Heng, H., et al. (2003). From DNA structure to gene expression: mediators of nuclear compartmentaliza-tion and dynamics. Chromosome Res. 11, 435-445.
15. Boscolo, S., Mion, F., Licciulli, M., et al. (2012). Simple scale-up of recombinant antibody production using an UCOE containing vector. N. Biotechnol. 29, 477-484.
16. Breda, L., Casu, C., Gardenghi, S., et al. (2012). Therapeutic hemoglobin levels after gene transfer in b-thalassemia mice and in hematopoietic cells of b-thalassemia and sickle cells disease patients. PLoS One 7, e32345.
17. Brendel, C., Mü ller-Kuller, U., Schultze-Strasser, S., et al. (2012). Physiological regulation of transgene expression by a lenti-viral vector containing the A2UCOE linked to a myeloid promoter. Gene Ther. 19, 1018-1029.
18. Cavazza, A., Moiani, A., and Mavilio, F. (2013). Mechanisms of retroviral integration and mutagenesis. Gene Ther. 24: 119-131.
19. Cavazzana-Calvo, M., Payen, E., Negre, O., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human b-thalassaemia. Nature 467, 318-322.
20. Cavazzana-Calvo, M., Fischer, A., Hacein-Bey-Abina, S., et al. (2012). Gene therapy for primary immunodeficiencies: Part 1. Curr. Opin. Immunol. 24, 580-584.
21. Chang, A.H., Stephan, M.T., and Sadelain, M. (2006). Stem cell-derived erythroid cells mediate long-term systemic protein delivery. Nat. Biotechnol. 24, 1017-1021.
22. Cherry, S.R., Biniszkiewicz, D., van Parijs, L., et al. (2000). Ret-roviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell. Biol. 20, 7419-7426.
23. Collis, P., Antoniou, M., and Grosveld, F. (1990). Definition of the minimal requirements within the human b-globin gene and the dominant control region for high level expression. EMBO J. 9, 233-240.
24. Dean, A. (2006). On a chromosome far, far away: LCRs and gene expression. Trends Genet. 22, 38-45.
25. Dean, A. (2011). In the loop: long range chromatin interactions and gene regulation. Brief Funct. Genomics 10, 3-10.
26. de Laat, W., and Grosveld, F. (2003). Spatial organization of gene expression: the active chromatin hub. Chromosome Res. 11, 447-459.
27. Diaz, P., Cado, D., and Winoto, A. (1994). A locus control region in the T cell receptor alpha/delta locus. Immunity 1: 207-217.
28. Dong, A., Rivella, S., and Breda, L. (2013). Gene therapy for hemoglobinopathies: progress and challenges. Transl. Res. pii: S1931-5244(12)00447-1. doi: 10.1016/j.trsl.2012.12.011. [Epub ahead of print]
29. Dzierzak, E.A., Papayannopoulou, T., and Mulligan, R.C. (1988). Lineage-specific expression of a human b-globin gene in mu-rine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331, 35-41.
30. Ellis, J. (2005). Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 16, 1241-1246.
31. Emery, D.W. (2011). The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors. Hum. Gene Ther. 22, 761-774.
32. Festenstein, R., Tolaini, M., Corbella, P., et al. (1996). Locus control region function and heterochromatin-induced position effect variegation. Science 271, 1123-1125.
33. Fields, P.E., Lee, G.R., Kim, S.T., et al. (2004) Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21, 865-876.
34. Ghirlando, R., Giles, K., Gowher, H., et al. (2012). Chromatin domains, insulators, and the regulation of gene expression. Biochim. Biophys. Acta 1819, 644-651.
35. Girod, P.A., Nguyen, D.Q., Calabrese, D., et al. (2007). Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nat. Methods 4, 747-753.
36. Gomos-Klein, J., Harrow, F., Alarcón, J., et al. (2007). CTCF-independent, but not CTCF-dependent, elements significantly contribute to TCR-alpha locus control region activity. J. Immunol. 179, 1088-1095.
37. Greaves, D.R., Wilson, F.D., Lang, G., et al. (1989). Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell 56, 979-986.
38. Grosveld, F., van Assendelft, G. B., Greaves, D. R., et al. (1987). Position-independent, high-level expression of the human b-globin gene in transgenic mice. Cell 51, 975-985.
39. Hargrove, P.W., Kepes, S., Hanawa, H., et al. (2008). Globin lentiviral vector insertions can perturb the expression of endogenous genes in b-thalassemic hematopoietic cells. Mol. Ther. 16, 525-533.
40. Harland, L., Crombie, R., Anson, S., et al. (2002). Transcriptional regulation of the human TATA binding protein gene. Geno-mics 74, 479-482.
41. Harraghy, N., Regamey, A., Girod, P.A., et al. (2011). Identification of a potent MAR element from the mouse genome and assessment of its activity in stable and transient transfections. J. Biotechnol. 154, 11-20.
42. Heng, H.H., Goetze, S., Ye, C.J., et al. (2004). Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J. Cell Sci. 117, 999-1008.
43. Higgs, D.R., Engel, J.D., and Stamatoyannopoulos, G. (2012). Thalassaemia. Lancet 379, 373-383.
44. Indraccolo, S., Minuzzo, S., Roccaforte, F., et al. (2001). Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. Blood 98, 3607-3617.
45. Jones, B.K., Monks, B.R., Liebhaber, S.A., et al. (1995). The human growth hormone gene is regulated by a multicomponent locus control region. Mol. Cell. Biol. 15, 7010-7021.
46. Kaptein, L.C.M., Breuer, M., Valerio, D., et al. (1998). Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo. Gene Ther. 5, 320-330.
47. Katsantoni, E.Z., Anghelescu, N.E., Robbert Rottier, R., et al. (2007). Ubiquitous expression of the rtTA2S-M2 inducible system in transgenic mice driven by the human HNRNPA2B1/CBX3 CpG island. BMC Dev. Biol. 7:108.
48. Kim, A., and Dean, A. (2012). Chromatin loop formation in the b-globin locus and its role in globin gene transcription. Mol. Cells 34, 1-5.
49. Klug, C.A., Cheshier, S., and Weissman, I.L. (2000). Inactivation of a GFP retrovirus occurs at multiple levels in long-term re-populating stem cells and their differentiated progeny. Blood 96, 894-901.
50. Knight, S., Zhang, F., Mueller-Kuller, U., et al. (2012). Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J. Virol. 86, 9088-9095.
51. Kowolik, C.M., Hu, J., and Yee, J.K. (2001). Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression. J. Virol. 75, 4641-4648.
52. Krivega, I., and Dean, A. (2012). Enhancer and promoter interactions-long distance calls. Curr. Opin. Genet. Dev. 22, 79-85.
53. Lang, G., Mamalaki, C., Greenberg, D., et al. (1991). Deletion analysis of the human CD2 gene locus control region in transgenic mice. Nucleic Acids Res. 19, 5851-5856.
54. Leboulch, P., Huang, G.M.S., Humphries, R.K., et al. (1994). Mutagenesis of retroviral vectors transducing human b-globin gene and b-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 13, 3065-3076.
55. Lee, G.R., Fields, P.E., Griffin, T.J., et al. (2003). Regulation of the Th2 cytokine locus by a locus control region. Immunity 19, 145-153.
56. Li, Q., Peterson, K.R., Fang, X. et al. (2002). Locus control regions. Blood 100, 3077-3086.
57. Lindahl Allen, M., and Antoniou, M. (2007). Correlation of DNA methylation with histone modifications across the HNRPA2B1-CBX3 ubiquitously-acting chromatin open element (UCOE). Epigenetics 2, 227-236.
58. Lisowski, L., and Sadelain, M. (2007). Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in b-thalassemic mice. Blood 110, 4175-4178.
59. Lutzko, C., Senadheera, D., Skelton, D., et al. (2003). Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes. J. Virol. 77, 7341-7351.
60. May, C., Rivella, S., Callegari, J., et al. (2000). Therapeutic haemoglobin synthesis in b-thalassaemic mice expressing lenti-virus-encoded human b-globin. Nature 406, 82-86.
61. Miccio, A., Cesari, R., Lotti, F., et al. (2008). In vivo selection of genetically modified erythroblastic progenitors leads to longterm correction of b-thalassemia. Proc. Natl. Acad. Sci. U.S.A. 105, 10547-10552.
62. Miccio, A., Poletti, V., Tiboni, F., et al. (2011). The GATA1-HS2 enhancer allows persistent and position-independent expression of a b-globin transgene. PLoS One 6, e27955.
63. Minoguchi, S., and Iba, H. (2008). Instability of retroviral DNA methylation in embryonic stem cells. Stem Cells 26, 1166-1173.
64. Moiani, A., Paleari, Y., Sartori, D., et al. (2012). Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts. J. Clin. Invest. 122, 1653-1666.
65. Mok, H.P., Javed, S., and Lever, A. (2007). Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority. Gene Ther. 14, 741-751.
66. Montiel-Equihua, C.A., Zhang, L., Knight, S., et al. (2012). The b-globin locus control region in combination with the EF1a short promoter allows enhanced lentiviral vector-mediated ery-throid gene expression with conserved multilineage activity. Mol. Ther. 20, 1400-1409.
67. Murawska, M., and Brehm, A. (2011). CHD chromatin re-modelers and the transcription cycle. Transcription 2, 244-253.
68. Nair, A.R., Jinger, X., and Hermiston, T.W. (2011). Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII. BMC Res. Notes 4, 178.
69. Naldini, L. (2011). Ex vivo gene transfer and correction for cell-based therapies. Nat. Rev. Genet. 12, 301-315.
70. Noordermeer, D., Branco, M.R., Splinter, E., et al. (2008). Transcription and chromatin organization of a housekeeping gene cluster containing an integrated b-globin locus control region. PLoS Genet. 4, e1000016.
71. Ott, M.G., Schmidt, M., Schwarzwaelder, K., et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12, 401-409.
72. Palstra, R.J., de Laat, W., and Grosveld, F. (2008). b-globin regulation and long-range interactions. Adv. Genet. 61, 107-142.
73. Pannell, D., Osborne, C.S., Yao, S., et al. (2000). Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J. 19, 5884-5894.
74. Parera, M., Ibañez, A., Clotet, B. et al. (2004). Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy. J. Infect. Dis. 189, 1444-1451.
75. Park, F., and Kay, M.A. (2001). Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol. Ther. 4, 164-173.
76. Pennisi, E. (2012). Genomics. ENCODE project writes eulogy for junk DNA. Science 337, 1159.
77. Perumbeti, A., and Malik, P. (2010). Genetic correction of sickle cell anemia and b-thalassemia: progress and new perspective. ScientificWorldJournal 10, 644-654.
78. Pfaff, N., Lachmann, N., Ackermann, M., et al. (2013). A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny. Stem Cells 31, 488-499.
79. Puthenveetil, G., Scholes, J., Carbonell, D., et al. (2004). Successful correction of the human b-thalassemia major pheno-type using a lentiviral vector. Blood 104, 3445-3453.
80. Raguz, S., Hobbs, C., Yagüe, E., et al. (1998). Muscle-specific locus control region activity associated with the human des-min gene. Dev. Biol. 201, 26-42.
81. Ramezani, A., and Hawley, R.G. (2010). Strategies to insulate lentiviral vector-expressed transgenes. Methods Mol. Biol. 614, 77-100.
82. Ramezani, A., Hawley, T.S., and Hawley, R.G. (2003). Performanceand safety-enhanced lentiviral vectors containing the human interferon-b scaffold attachment region and the chicken b-globin insulator. Blood 101, 4717-4724.
83. Rivella, S., May, C., Chadburn, A., et al. (2003). A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human b-globin gene transfer. Blood 101, 2932-2939.
84. Roselli, E.A., Mezzadra, R., Frittoli, M.C., et al. (2010). Correction of b-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients. EMBO Mol. Med. 2, 315-328.
85. Rosenqvist, N., Hård Af Segerstad, C., Samuelsson, C., et al. (2002). Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation. J. Gene Med. 4, 248-257.
86. Sadelain, M., Wang, C.H., Antoniou, M., et al. (1995). Generation of a high-titer retroviral vector capable of expressing high levels of the human b-globin gene. Proc. Natl. Acad. Sci. U.S.A. 92, 6728-6732.
87. Sadelain, M., Chang, A., and Lisowski, L. (2009). Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells. Mol. Ther. 117, 1994-1999.
88. Samakoglu, S., Lisowski, L., Budak-Alpdogan, T., et al. (2006). A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat. Bio-technol. 24, 89-94.
89. Sanyal, A., Lajoie, B.R., Jain, G., et al. (2012). The long-range interaction landscape of gene promoters. Nature 489, 109-113.
90. Sharma, N., Hollensen, A.K., Bak, R.O., et al. (2012). The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. PLoS One 7, e48421.
91. Smolle, M., Workman, J.L., and Venkatesh, S. (2013). reSETting chromatin during transcription elongation. Epigenetics 8, 10-15.
92. Stein, S., Ott, M.G., Schultze-Strasser, S., et al. (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granuloma-tous disease. Nat. Med. 16, 198-204.
93. Taher, T.E., Tulone, C., Fatah, R., et al. (2008). Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors. Gene Ther. 15, 998-1006.
94. Talbot, G.E., Waddington, S.N., Bales, O., et al. (2010). Desmin-regulated lentiviral vectors for skeletal muscle gene transfer. Mol. Ther. 18, 601-608.
95. Tam, J.L.Y., Triantaphyllopoulos, K., Todd, H., et al. (2006). The human desmin locus: gene organisation and LCR-mediated transcriptional control. Genomics 87, 733-746.
96. Uchiyama, T., Adriani, M., Jagadeesh, G.J., et al. (2012). Foamy virus vector-mediated gene correction of a mouse model of Wiskott-Aldrich syndrome. Mol. Ther. 20, 1270-1279.
97. Wijgerde, M., Grosveld, F., and Fraser, P. (1995). Transcription complex stability and chromatin dynamics in vivo. Nature 377, 209-213.
98. Williams, S., Mustoe, T., Mulcahy, T., et al. (2005). CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol. 5, 17.
99. Wilson, R.H., and Coverley, D. (2013). Relationship between DNA replication and the nuclear matrix. Genes Cells 18, 17-31.
100. Winkler, D.D., and Luger, K. (2011). The histone chaperone FACT: structural insights and mechanisms for nucleosome reorganization. J. Biol. Chem. 286, 18369-18374.
101. Xia, X., Zhang, Y., Zieth, C.R., et al. (2007). Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 16, 167-176.
102. Yang, J., and Corces, V.G. (2012). Insulators, long-range interactions, and genome function. Curr. Opin. Genet. Dev. 22, 86-92.
103. Zhang, F., Thornhill, S.I., Howe, S.J., et al. (2007). Lentiviral vectors containing an enhancer-less ubiquitously-acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in haematopoietic cells. Blood 110, 1448-1457.
104. Zhang, F., Frost, A.F., Blundell, M., et al. (2010). A Ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation mediated silencing of lentiviral vectors. Mol. Ther. 18, 1640-1649.